These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33799794)

  • 21. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intact blood-brain barrier during spontaneous attacks of migraine without aura: a 3T DCE-MRI study.
    Amin FM; Hougaard A; Cramer SP; Christensen CE; Wolfram F; Larsson HBW; Ashina M
    Eur J Neurol; 2017 Sep; 24(9):1116-1124. PubMed ID: 28727225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in hippocampal volume during a preceding 10-year period do not correlate with cognitive performance and hippocampal blood‒brain barrier permeability in cognitively normal late-middle-aged men.
    Bakhtiari A; Vestergaard MB; Benedek K; Fagerlund B; Mortensen EL; Osler M; Lauritzen M; Larsson HBW; Lindberg U
    Geroscience; 2023 Apr; 45(2):1161-1175. PubMed ID: 36534276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison Between Blood-Brain Barrier Water Exchange Rate and Permeability to Gadolinium-Based Contrast Agent in an Elderly Cohort.
    Shao X; Jann K; Ma SJ; Yan L; Montagne A; Ringman JM; Zlokovic BV; Wang DJJ
    Front Neurosci; 2020; 14():571480. PubMed ID: 33328848
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE.
    Chaganti J; Zeng G; Tun N; Lockart I; Abdelshaheed C; Cysique L; Montagnese S; Brew BJ; Danta M
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-Brain Barrier Disruption After Cardiopulmonary Bypass: Diagnosis and Correlation to Cognition.
    Abrahamov D; Levran O; Naparstek S; Refaeli Y; Kaptson S; Abu Salah M; Ishai Y; Sahar G
    Ann Thorac Surg; 2017 Jul; 104(1):161-169. PubMed ID: 28193536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omega-3 fatty acids are associated with blood-brain barrier integrity in a healthy aging population.
    Barnes S; Chowdhury S; Gatto NM; Fraser GE; Lee GJ
    Brain Behav; 2021 Aug; 11(8):e2273. PubMed ID: 34327870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.
    Chai WY; Chu PC; Tsai MY; Lin YC; Wang JJ; Wei KC; Wai YY; Liu HL
    J Control Release; 2014 Oct; 192():1-9. PubMed ID: 24969355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron leakage owing to blood-brain barrier disruption in small vessel disease CADASIL.
    Uchida Y; Kan H; Sakurai K; Arai N; Inui S; Kobayashi S; Kato D; Ueki Y; Matsukawa N
    Neurology; 2020 Sep; 95(9):e1188-e1198. PubMed ID: 32586899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered Vascular Permeability in Migraine-associated Brain Regions: Evaluation with Dynamic Contrast-enhanced MRI.
    Kim YS; Kim M; Choi SH; You SH; Yoo RE; Kang KM; Yun TJ; Lee ST; Moon J; Shin YW
    Radiology; 2019 Sep; 292(3):713-720. PubMed ID: 31264949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies.
    Raja R; Rosenberg GA; Caprihan A
    Neuropharmacology; 2018 May; 134(Pt B):259-271. PubMed ID: 29107626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study.
    Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L
    Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring the integrity of the human blood-brain barrier using magnetic resonance imaging.
    Kassner A; Thornhill R
    Methods Mol Biol; 2011; 686():229-45. PubMed ID: 21082374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The quantification of blood-brain barrier disruption using dynamic contrast-enhanced magnetic resonance imaging in aging rhesus monkeys with spontaneous type 2 diabetes mellitus.
    Xu Z; Zeng W; Sun J; Chen W; Zhang R; Yang Z; Yao Z; Wang L; Song L; Chen Y; Zhang Y; Wang C; Gong L; Wu B; Wang T; Zheng J; Gao F
    Neuroimage; 2017 Sep; 158():480-487. PubMed ID: 27402601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer's disease (DEBBIE-AD): a prospective observational multicohort study protocol.
    Padrela B; Mahroo A; Tee M; Sneve MH; Moyaert P; Geier O; Kuijer JPA; Beun S; Nordhøy W; Zhu YD; Buck MA; Hoinkiss DC; Konstandin S; Huber J; Wiersinga J; Rikken R; de Leeuw D; Grydeland H; Tippett L; Cawston EE; Ozturk-Isik E; Linn J; Brandt M; Tijms BM; van de Giessen EM; Muller M; Fjell A; Walhovd K; Bjørnerud A; Pålhaugen L; Selnes P; Clement P; Achten E; Anazodo U; Barkhof F; Hilal S; Fladby T; Eickel K; Morgan C; Thomas DL; Petr J; Günther M; Mutsaerts HJMM
    BMJ Open; 2024 Mar; 14(3):e081635. PubMed ID: 38458785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Blood Brain Barrier Leakage with Gadolinium-Enhanced MRI.
    Ku MC; Waiczies S; Niendorf T; Pohlmann A
    Methods Mol Biol; 2018; 1718():395-408. PubMed ID: 29341021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.